TrialJournal of hepatology2020

Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma.

Bruno Sangro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.